Graphene-Based Platforms for Cancer Therapeutics
- 15 January 2016
- journal article
- review article
- Published by Taylor & Francis in Therapeutic Delivery
- Vol. 7 (2) , 101-116
Abstract
Graphene is a multifunctional carbon nanomaterial and could be utilized to develop platform technologies for cancer therapies. Its surface can be covalently and noncovalently functionalized with anticancer drugs and functional groups that target cancer cells and tissue to improve treatment efficacies. Furthermore, its physicochemical properties can be harnessed to facilitate stimulus responsive therapeutics and drug delivery. This review article summarizes the recent literature specifically focused on development of graphene technologies to treat cancer. We will focus on advances at the interface of graphene based drug/gene delivery, photothermal/photodynamic therapy and combinations of these techniques. We also discuss the current understanding in cytocompatibility and biocompatibility issues related to graphene formulations and their implications pertinent to clinical cancer management.Keywords
This publication has 128 references indexed in Scilit:
- Functionalized Graphene Oxide Mediated Adriamycin Delivery and miR-21 Gene Silencing to Overcome Tumor Multidrug Resistance In VitroPLOS ONE, 2013
- Recent advances in graphene family materials toxicity investigationsJournal of Nanoparticle Research, 2012
- Central Role of the EGF Receptor in Neurometabolic AgingInternational Journal of Endocrinology, 2012
- Physicochemical Characterization, and Relaxometry Studies of Micro-Graphite Oxide, Graphene Nanoplatelets, and NanoribbonsPLOS ONE, 2012
- Aerosol Synthesis of Cargo-Filled Graphene NanosacksNano Letters, 2012
- Photothermally Enhanced Drug Delivery by Ultrasmall Multifunctional FeCo/Graphitic Shell NanocrystalsACS Nano, 2011
- Barriers to Non-Viral Vector-Mediated Gene Delivery in the Nervous SystemPharmaceutical Research, 2011
- Nano-graphene oxide for cellular imaging and drug deliveryNano Research, 2008
- PEGylated Nanographene Oxide for Delivery of Water-Insoluble Cancer DrugsJournal of the American Chemical Society, 2008
- Epidermal Growth Factor Receptor Inhibitor–Associated Cutaneous Toxicities: An Evolving Paradigm in Clinical ManagementThe Oncologist, 2007